Trade Summary

4 days ago, STEPHENSON BRIAN C, serving as Chief Financial Officer at Faeth Therapeutics, Inc. (FTH), purchased 15,641 shares at $25.65 per share, for a total transaction value of $401,268.52. Following this transaction, STEPHENSON BRIAN C now holds 33,054 shares of FTH.

This purchase represents a 89.82% increase in STEPHENSON BRIAN C's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Wednesday, June 24, 2026 and publicly disclosed via SEC Form 4 filing on Friday, June 26, 2026 at 7:40 PM ET, 2 days after the trade was made.

Faeth Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.